Literature DB >> 7912087

Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals.

S C Tayal, K N Sankar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7912087     DOI： 10.1097/00002030-199404000-00024

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

Review 1.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

Review 2.  Old and new adjuvants for hepatitis B vaccines.

Authors:  Geert Leroux-Roels
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

Review 3.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

4.  Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men.

Authors:  Ligia A Pinto; Timothy J Wilkin; Troy J Kemp; Martha Abrahamsen; Kimberly Isaacs-Soriano; Yuanji Pan; Jennifer Webster-Cyriaque; Joel M Palefsky; Anna R Giuliano
Journal:  Vaccine       Date:  2019-03-30       Impact factor: 3.641

5.  Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.

Authors:  Patricia M Flynn; Coleen K Cunningham; Bret Rudy; Craig M Wilson; Bill Kapogiannis; Carol Worrell; James Bethel; Dina Monte; Kelly Bojan
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

6.  Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study.

Authors:  Phyllis C Tien; Andrea Kovacs; Peter Bacchetti; Audrey L French; Michael Augenbraun; Stephen R Cole; Nancy Hessol; Jessica Justman
Journal:  Clin Infect Dis       Date:  2004-10-07       Impact factor: 9.079

Review 7.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

Review 8.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.

Authors:  Erna Milunka Kojic; Minhee Kang; Michelle S Cespedes; Triin Umbleja; Catherine Godfrey; Reena T Allen; Cynthia Firnhaber; Beatriz Grinsztejn; Joel M Palefsky; Jennifer Y Webster-Cyriaque; Alfred Saah; Judith A Aberg; Susan Cu-Uvin
Journal:  Clin Infect Dis       Date:  2014-04-09       Impact factor: 9.079

10.  Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Anuradha Ganesan; Amy C Weintrob; Nancy F Crum-Cianflone; R Vincent Barthel; Robert J O'Connell; Ann Fieberg; Helen M Chun; Vincent C Marconi; Matthew J Dolan; Brian K Agan
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.